INTRODUCTION {#sec1-1}
============

Rabies is a fatal viral zoonotic disease which causes encephalitis in all warm-blooded animals, including humans, continued to be a serious problem in Africa.\[[@ref1]\] Rabies, a disease known to humanity for over 100 years, is till date considered a fatal killer once the symptoms begin to appear. The burden of the disease is quite high with nearly 55,000 people dying of this dreadful disease globally, of which approximately 29,000 deaths being reported annually from India alone.

Rabies caused by a single-stranded, negative-sense RNA virus is maintained in nature by a variety of animal reservoirs and primarily infects the central nervous system (CNS), resulting in progressive encephalopathy and ultimately death in an infected human.\[[@ref2]\]

Rabies prevention can be achieved by elimination of exposure and by vaccination through PE prophylaxis and postexposure treatment.\[[@ref3]\] PE rabies prophylaxis affords a measure of protection for unrecognized rabies exposures and simplifies postexposure treatment. Postexposure treatment is recommended following exposure to a potentially rabid animal and involves treatment of wound and administration of rabies vaccine as well as rabies immunoglobulin for individuals not previously vaccinated. Despite the availability of prevention and prophylaxis measures, rabies continues to be a threat globally.

Rabies is an acute viral infection of the CNS that is usually fatal in humans and animals. Rabies causes about 55,000 human deaths annually worldwide, with 95% of human deaths due to rabies occur in Asia and Africa. India has the highest rate of human rabies in the world, primarily because of stray dogs, whose number has greatly increased since a 2001 law forbade the killing of dogs. A total of 20,000 people are estimated to die every year from rabies in India more than one-third of the global toll.\[[@ref4][@ref5]\]

Plants serve as a source to treat different ailments.\[[@ref6]\] Many useful drugs have been developed from medicinal plants used in traditional medicine in the treatment of a variety of illnesses.\[[@ref7]\]

*Datura* has long been used as an extremely effective treatment for asthma symptoms. The active antiasthmatic agent is atropine, which causes paralysis of the pulmonary branches of the lungs, eliminating the spasms that cause the asthma attacks. The leaves are generally smoked either in a cigarette or a pipe. This practice of smoking *Datura* to relieve asthma has its origins in traditional ayurvedic medicine in India. *Datura* also has a wide range of traditional application including epilepsy, hysteria, insanity, heart, and skin diseases. It also cures mental diseases and relieves pain.\[[@ref8]\]

Therapeutic human rabies immunoglobulin and vaccine are available against rabies virus, but it is ineffective once the virus enters the CNS. There was only one reported case of a female survival from rabies virus by inducing coma and treating her with a combination of known antiviral drugs (Milwaukee protocol).\[[@ref9]\] Therefore, the search for more effective antiviral agents against viral infections of the CNS is a necessary and highly desirable task. This necessitates the need for the development of novel antivirals against rabies virus. Plant secondary metabolites have tremendous potential to be antiviral agents.

The potential of *Datura* plant extract was exhibited by *in vitro* model where *Datura* extract was found to have a pronounced *in vitro* antirabies activity.\[[@ref10]\]

However, the *in vivo* antiviral potential of *Datura* was not explored earlier. This study intended to evaluate the *in vivo* antirabies activity of *Datura* extract in a murine model.

MATERIALS AND METHODS {#sec1-2}
=====================

Collection of plant material {#sec2-1}
----------------------------

*Datura* fruit was collected from the Phool market, Dadar, Mumbai. Plant specimen was authenticated and deposited in Blatter Herbarium, Department of Botany, St. Xavier\'s College, Mumbai, Maharashtra, India.

Preparation of plant extracts {#sec2-2}
-----------------------------

The *Datura* seed separated from the fruit and was air dried and then was soaked in cow urine for 12 h. After 12 h, the seed was separated from the cow urine and air-dried. The dried seed was then boiled for 3 h in cow milk. After treatment with milk, the *Datura* seed was separated from the milk, and the seed cover was peeled out from the *Datura* seed. The peeled *Datura* seed was air-dried and then fine grinded and stored for further use. During processing, the seed powder was dissolved in water and was used for the antiviral assay.\[[@ref11]\]

Animal study {#sec2-3}
------------

Swiss albino mice aged from 4 to 6 weeks were purchased from Haffkine Institute (animal house), and the study was approved by the Institutional Animal Ethics Committee (IAEC) HITRT/IAEC/19/2013. The challenged virus standard strain of fixed rabies virus (RV CVS) was passaged in Swiss albino mice (30 μl intracerebrally) to increase the virus titer, and RV CVS stock suspension (10% w/v) was stored at −80°C. The LD~50~ dose was calculated by Reed and Muench method, and based on the 1 LD~50~ of the RV CVS, a challenge dose of 10 LD~50~ RV CVS was used in PE and postexposure treatments with *Datura* extracts.\[[@ref12]\]

*In vivo* toxicity of *Datura* extracts {#sec2-4}
---------------------------------------

The oral toxicity study was performed using fixed dose method (OECD guideline no. 420). The mice (3 weeks old) were provided from the Animal House Department, Haffkine Institute for the acute oral toxicity of the *Datura* extracts.

A single dose of *Datura metel* extracts was prepared as per 2000 mg/kg body weight of the Swiss albino mice for the fixed dose method. Swiss albino mice were grouped as per the sex and weight of the animal, and six mice per test group were considered for the toxicity study.

The concentration of 2000 mg/kg each extract was administered orally in the test group and observed for 21 days for mortality and morbidity. After 21 days, the animals were sacrificed and the toxicity was observed in major viral organs by for histopathological examination.\[[@ref12]\]

Titration of stock virus {#sec2-5}
------------------------

The challenge virus (RV CVS) was stored as a 10% suspension in −80°C in the ampule/cryovials. Shortly before the test is carried out, a vial is taken from the stock and thawed rapidly under the tap. Serial tenfold dilution was then prepared (10^−\ 1^ up to10^−\ 7^) in the vials and the LD~50~ was calculated.\[[@ref13]\]

Preexposure treatment {#sec2-6}
---------------------

In the PE treatment, the test group of Swiss albino mice (10 mice/group) was administered orally (20 mg/ml) with the single dose of *Datura* extracts for 3 days, followed by the challenge dose of (30 μL intracerebrally) 10 LD RV CVS was inoculated onto the test (PE) Swiss albino mice. The virus control group of mice (10 mice/group) was inoculated intracerebrally with 10 LD~50~ RV CVS. Postinfection (PI) after 6 h, the test groups were orally administered (20 mg/ml) *Datura* extract for 14 days. All the group of mice was observed mortality up to 21 days.\[[@ref14]\]

Postexposure treatment {#sec2-7}
----------------------

In the postexposure treatment, the test group of Swiss albino mice (10 mice/group) was inoculated intracerebrally (30 μl) with the challenge dose of 10 LD~50~ RV CVS followed by the oral administration (after 6 h) of the *Datura* extracts (20 mg/ml) in the test group of mice. The virus control group (10 mice/group) of mice was inoculated intracerebrally with 10 LD~50~ RV CVS and the extract control group (10 mice/group) of mice was administered with the *Datura* extracts. The test group and the extract control group of mice (10 mice each) were administered up to 14 days and all the groups of mice were observed mortality up to 21 days.\[[@ref14]\]

Virus-releasing study by titration {#sec2-8}
----------------------------------

The infected brain suspension was serially diluted in medium and infected in a 96 well plate with vero cell line and incubated for 72 h in a 37°C, CO~2~ incubator for virus titration. After incubation, the infected cells were fixed with chilled acetone and stained with FITC-tagged antibodies and were observed under a fluorescent inverted microscope. The viral load was calculated by TCID50 titration method and the virus titer was determined by fluorescent antibody test method.\[[@ref10]\]

Statistical analysis {#sec2-9}
--------------------

Statistical analysis was performed using two-way analysis of variance test with GraphPad Prism 5.1 software Inc, (La Jolla California USA).

RESULTS AND DISCUSSION {#sec1-3}
======================

*In vivo* toxicity of crude extracts {#sec2-10}
------------------------------------

*Datura* extract was not found to be toxic up to 2000 mg/kg body weight of Swiss albino mice, i.e., 60 mg/30 g of mice when administered (0.5 ml) orally and observed till 21 days. The LD~50~ titer was calculated by the Reed and Muench method. The titer of 10^4.75^ LD~50~/0.03 ml RV CVS (1 LD~50~) was obtained. Based on the 1 LD~50~, the challenge dose of 10 LD~50~ RV CVS was used for the *in vivo* antirabies activity by PE and postexposure treatment.

In a PE treatment, we observed 20% survival rate on the test group (PE of *Datura* extracts) even after 21 days PI as compared to the virus control group of mice where mortality was observed on 10 day PI \[[Figure 1](#F1){ref-type="fig"}\].

![Pre-exposure treatment of *Datura* (ayurvedic) extracts against a challenge dose of 10 LD~50~ challenged virus standard strain of fixed rabies virus. The results are expressed as standard error of the mean for each Group](PR-10-109-g002){#F1}

In a postexposure treatment, no survival rate was observed in the test group; however, survival time was increased by 4 days in the test group of mice as compared to the virus control group of mice where the mortality was observed in 10 days PI \[[Figure 2](#F2){ref-type="fig"}\].

![Postexposure treatment of *Datura* (ayurvedic) extracts against a challenge dose of 10 LD~50~ challenged virus standard strain of fixed rabies virus. The results are expressed as standard error of the mean for each Group](PR-10-109-g003){#F2}

*In vivo* titration of the infected brain for rabies virus {#sec2-11}
----------------------------------------------------------

*In vivo*, antirabies activity of *Datura* extracts was evaluated in Swiss albino mice when challenged with 10 LD~50~ RV CVS by PE and postexposure treatment. The infected test brains along with the virus control brains were harvested and titrated in vero cell line to determine the presence of the virus and the virus titer as compared with the virus control.

We observed 3 log and 1 log decreased in the virus titer of the test group of *Datura* PE treated and *Datura* postexposure treated infected brain suspension, respectively, as compared to the virus control brain suspension. The *Datura* (PE and postexposure) treatment significantly reduced the viral load in the Swiss albino mice when challenged with the 10 LD~50~ RV CVS as compared with the virus control \[[Figure 3](#F3){ref-type="fig"}\].

![Titration of the test and virus control infected brain suspension. The results are expressed as standard error of the mean for each Group](PR-10-109-g004){#F3}

A single dose of *Datura* extracts (20 mg/ml) was administered orally followed by a challenge dose of 10 LD~50~ RV CVS (30 μl) inoculated intracerebrally in (3 weeks old) Swiss albino mice for both PE and postexposure trail experiment. In the PE treatment of *Datura* extract, we observed 20% survival rate on the test group up to 14 days PI as compared to the virus control group of mice where mortality was observed on 10 days PI. However, in the postexposure treatment, no survival rate was observed as the test group mice died as compared to the virus control group. However, survival time was increased by 4 days in the test group of mice as compared to the virus control group of mice where the mortality was observed in 10 days PI.

In the similar study, it was found that when the mice were administered with 1000 mg/kg dose of hydroethanolic extract Phytolacca dodecandra leaves, 33.3% survival rate was observed when challenged with rabies virus as compared to the virus control. However, 10% survival rate was found at the 600 mg/kg dose of the extract in mice and no survival was at 300 mg/kg dose of hydroethanolic extract P. dodecandra leaves when challenged with rabies virus as compared to the virus control.\[[@ref15]\]

*Datura* is a wild plant having various medicinal and pharmacological properties. Phytochemical of the plant are alkaloids, atropine, scopolamine, tannin, saponins, glycosides, phenol, sterols, lignins, fats, carbohydrates, and proteins.\[[@ref16]\]

*Datura* plant contains high levels of tropane alkaloids such as atropine, hyoscyamine, and scopolamine. Atropine and scopolamine are muscarinic antagonists which can be used to treat Parkinson\'s diseases and parasympathetic stimulation of the eye, heart, urinary, respiratory, and gastrointestinal tract. Anticholinergics are a class of compounds that inhibit parasympathetic nerve impulses by selectively blocking the binding of the neurotransmitter acetylcholine to its receptor in nerve cells. Atropine is an anticholinergic agent that blocks the neurotransmitter acetylcholine in the central and the peripheral nervous system. Rabies virus also interacts with the acetylcholine receptor in the CNS.\[[@ref17]\]

In the study, we observed efficacy in the PE treatment with *Datura* extract but in the postexposure treatment where the infection is established in the CNS, only the survival time was increased but no protection was observed. The possible mechanism might be the masking the acetylcholine receptors and preventing the entry and thereby neutralizing the virus. Earlier studies suggest that *D. metel* extracts have a wide range of antibacterial and antifungal activity.\[[@ref18]\]

*In vitro* study of *Datura* extract exhibited antirabies activity.\[[@ref10]\] We observed that in *in vivo* study of *Datura* exhibited promising antirabies activity. The *Datura* extract prolonged the survival time by 4 days in the postexposure treatment whereas 20% survival rate was observed in the PE treatment in a murine model. Further research needs to be done on the mechanism of *Datura* to assess its protective role in rabies treatment.

CONCLUSION {#sec1-4}
==========

*Datura* extract has an *in vivo* antirabies activity, as 20% survival rate was observed in the PE treatment. Moreover, also the survival time was increased in the PE treatment after the disease was established in a murine model. Further research needs to be done on the mechanism of *Datura* to assess its protective role in rabies treatment.
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